Studies that report the role of UBE2V2 in cancer are comparatively few, the gene is reported to be associated with poor prognosis in breast cancer [49] while the suppression of the gene in colorectal carcinoma cells is known to reverse oxaliplatin resistance [50]. This evidence concerns the gene UBE2V2 and breast carcinoma.